1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. CANCER GENE THERAPY MARKET BY THERAPY TYPE
5.1. Introduction
5.2. Immunotherapy
5.3. Oncolytic Virotherapy
5.4. Gene Transfer
5.5. Others
6. CANCER GENE THERAPY MARKET BY VECTOR TYPE
6.1. Introduction
6.2. Viral
6.3. Non-Viral
7. CANCER GENE THERAPY MARKET BY CANCER TYPE
7.1. Introduction
7.2. Breast
7.3. Lungs
7.4. Pancreas
7.5. Prostate
7.6. Others
8. CANCER GENE THERAPY MARKET BY END-USER
8.1. Introduction
8.2. Hospitals & Clinics
8.3. Diagnostic & Research Institutes
8.4. Others
9. CANCER GENE THERAPY MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. United States
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. United Kingdom
9.4.2. Germany
9.4.3. France
9.4.4. Spain
9.4.5. Others
9.5. Middle East & Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia Pacific
9.6.1. Japan
9.6.2. China
9.6.3. India
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Shanghai Sunway Biotech Co. Ltd
11.2. Amgen Inc.
11.3. Novartis
11.4. Gilead Sciences, Inc.
11.5. Bluebirdbio, Inc
11.6. Bristol Myers Squibb
11.7. GlaxoSmithKline plc
11.8. ElevateBio
11.9. Sangamo Therapeutics
11.10. BeiGene Ltd.
12. RESEARCH METHODOLOGY
LIST OF FIGURES
LIST OF TABLES